These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 2596125

  • 1. Urinary gonadotropin fragment (UGF) measurements in the diagnosis and management of ovarian cancer.
    Cole LA, Nam JH.
    Yale J Biol Med; 1989; 62(4):367-78. PubMed ID: 2596125
    [Abstract] [Full Text] [Related]

  • 2. Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic mass.
    Cole LA, Nam JH, Chambers JT, Schwartz PE.
    Gynecol Oncol; 1990 Mar; 36(3):391-4. PubMed ID: 2318450
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA, Wang YX, Elliott M, Latif M, Chambers JT, Chambers SK, Schwartz PE.
    Cancer Res; 1988 Mar 01; 48(5):1356-60. PubMed ID: 3342414
    [Abstract] [Full Text] [Related]

  • 7. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers.
    Cole LA, Schwartz PE, Wang YX.
    Gynecol Oncol; 1988 Sep 01; 31(1):82-90. PubMed ID: 3044936
    [Abstract] [Full Text] [Related]

  • 8. Urinary gonadotropin fragment, a new tumor marker. IV. Use in endometrial cancers and uterine mixed mullerian tumors.
    Nam JH, Chambers JT, Schwartz PE, Cole LA.
    Gynecol Oncol; 1990 Dec 01; 39(3):352-7. PubMed ID: 2175287
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Urinary gonadotropin fragment measurement in the monitoring of trophoblastic disease].
    Fu CY, Cole LA, Kardana A.
    Zhonghua Fu Chan Ke Za Zhi; 1994 Aug 01; 29(8):475-7, 510-1. PubMed ID: 7835119
    [Abstract] [Full Text] [Related]

  • 11. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
    Cole LA, Tanaka A, Kim GS, Park SY, Koh MW, Schwartz PE, Chambers JT, Nam JH.
    Gynecol Oncol; 1996 Feb 01; 60(2):264-70. PubMed ID: 8631549
    [Abstract] [Full Text] [Related]

  • 12. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
    Badgwell D, Lu Z, Cole L, Fritsche H, Atkinson EN, Somers E, Allard J, Moore RG, Lu KH, Bast RC.
    Gynecol Oncol; 2007 Sep 01; 106(3):490-7. PubMed ID: 17532030
    [Abstract] [Full Text] [Related]

  • 13. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
    Neven P, Iles RK, Lee CL, Hudson CN, Shepherd JH, Chard T.
    Cancer; 1993 Jun 15; 71(12):4124-30. PubMed ID: 7685240
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Urinary gonadotropin fragment measurements in patients with lung and esophageal disease.
    D'Agostino RS, Cole LA, Ponn RB, Stern H, Schwartz PE.
    J Surg Oncol; 1992 Mar 15; 49(3):147-50. PubMed ID: 1548888
    [Abstract] [Full Text] [Related]

  • 16. [Diagnosis of ovarian tumor by measuring tumor markers].
    Fukatsu T, Nakashima N, Takeuchi J.
    Rinsho Byori; 1992 Feb 15; 40(2):133-8. PubMed ID: 1583785
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
    Schwartz PE, Cracchiolo BM, Cole LA.
    Anticancer Res; 1996 Feb 15; 16(4B):2135-9. PubMed ID: 8694533
    [Abstract] [Full Text] [Related]

  • 19. Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
    Schutter EM, Mijatovic V, Kok A, Van Kamp GJ, Verstraeten R, Verheijen RH.
    Anticancer Res; 1999 Feb 15; 19(6C):5551-7. PubMed ID: 10697615
    [Abstract] [Full Text] [Related]

  • 20. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
    Nozawa S, Udagawa Y, Ito K, Susumu N, Sasaki H, Aoki D.
    Gan To Kagaku Ryoho; 1993 Feb 15; 20(2):279-85. PubMed ID: 8434967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.